| Regenerative medicine in Europe: global competition and innovation governance. | |
| | |
MedLine Citation:
|
PMID: 21082895 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Leading European nations with strong biotech sectors, such as the UK and Germany, are investing heavily in regenerative medicine, seeking competitive advantage in this emerging sector. However, in the broader biopharmaceutical sector, the EU is outperformed by the USA on all metrics, reflecting longstanding problems: limited venture capital finance, a fragmented patent system, and relatively weak relations between academia and industry. The current global downturn has exacerbated these difficulties. The crisis comes at a time when the EU is reframing its approach to the governance of innovation and renewing its commitment to the goal of making Europe the leading player in the global knowledge economy. If the EU is to gain a competitive advantage in the regenerative medicine sector then it must coordinate a complex multilevel governance framework that encompasses the EU, member states and regional authorities. This article takes stock of Europe's current competitive position within the global bioeconomy, drawing on a variety of metrics in the three intersecting spheres of innovation governance: science, market and society. These data then provide a platform for reviewing the problems of innovation governance faced by the EU and the strategic choices that have to be confronted in the regenerative medicine sector. |
| | |
Authors:
|
Stuart Hogarth; Brian Salter |
Related Documents
:
|
15915185 - Advertising of medicines on new zealand television. 20869835 - The history of radiation use in medicine. 19848225 - Toward an evolutionary historiography and epistemology of medicine. the legacy of mirko... 21376895 - Acculturation in hispanics and childhood poisoning: are medicines and household cleaner... 21031065 - Controversy: is there a role for adjuvants in the management of male pattern hair loss? 12402695 - Emergency management of acute asthma. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Regenerative medicine Volume: 5 ISSN: 1746-076X ISO Abbreviation: Regen Med Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278116 Medline TA: Regen Med Country: England |
Other Details:
|
Languages: eng Pagination: 971-85 Citation Subset: IM |
Affiliation:
|
Global Biopolitics Research Group, King's College London, Strand Campus, London, WC2R 2LS, UK. stuart.hogarth@kcl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mining the extracellular matrix for tissue engineering applications.
Next Document: Missed cancerous lesions in emergency laparoscopic surgery: Retrospective study of 2074 cases.